Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tri Chemical Laboratories's EBIT per Share for the
three
months ended in Apr. 2026 was €0.42.
Its EBIT per Share for the trailing twelve months (TTM) ended in Apr. 2026 was €1.37.
During the past 12 months, the average EBIT per Share Growth Rate of Tri Chemical Laboratories was -0.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 19.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 14.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 18.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Tri Chemical Laboratories's EBIT per Share or its related term are showing as below:
FRA:22E'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -41 Med: 19 Max: 167.2
Current: 19
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Tri Chemical Laboratories was 167.20% per year. The lowest was -41.00% per year. And the median was 19.00% per year.
FRA:22E's 3-Year EBIT Growth Rate is ranked better than 77.74% of 1339
companies
in the Chemicals industry
Industry Median: -1.2
vs FRA:22E: 19.00
Tri Chemical Laboratories (FRA:22E) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Tri Chemical Laboratories EBIT per Share Related Terms
Tri Chemical Laboratories EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.37
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tri Chemical Laboratories (FRA:22E) has a EBIT per Share of €1.37 as of Apr. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Tri Chemical Laboratories and its competitors. According to the industry distribution chart, Tri Chemical Laboratories ranks #298 out of 1339 companies in the Chemicals industry, placing it in the top 22.3%.
Is Tri Chemical Laboratories' EBIT per Share too high?
Tri Chemical Laboratories' current EBIT per Share is €1.37. Based on the distribution chart, Tri Chemical Laboratories ranks #298 out of 1339 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Tri Chemical Laboratories has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tri Chemical Laboratories' EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tri Chemical Laboratories ranks #298 out of 1339 companies for EBIT per Share. This places Tri Chemical Laboratories in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Tri Chemical Laboratories and its competitors. Tri Chemical Laboratories's current EBIT per Share is €1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tri Chemical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Tri Chemical Laboratories (FRA:22E) is currently considered Significantly Undervalued. The stock's GF Value™ is €26.87, compared to a current price of €16.80 — trading 37.5% below its estimated fair value. The current EBIT per Share is €1.37. Tri Chemical Laboratories' overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Tri Chemical Laboratories (FRA:22E), the current EBIT per Share is €1.37 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tri Chemical Laboratories (FRA:22E) Overvalued in 2026?
Based on GuruFocus' analysis, Tri Chemical Laboratories stock appears to be undervalued.
The current stock price of €16.80 is trading 37.5% below its estimated GF Value™ of €26.87.
GuruFocus considers Tri Chemical Laboratories to be Significantly Undervalued.
Key valuation signals for FRA:22E:
EBIT per Share: €1.37
GF Value™: €26.87 vs. price of €16.80 (37.5% below fair value)
No single metric tells the full story. See the FRA:22E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:22E has been successfully added to your 
